Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Madrigal Pharmaceuticals	Theravance Biopharma	Nabriva Therapeutics	TG Therapeutics	Intra-Cellular Therapies
Symbol	NASDAQ:MDGL	NASDAQ:TBPH	NASDAQ:NBRV	NASDAQ:TGTX	NASDAQ:ITCI
Price Information
Current Price	$70.08	$22.84	$0.57	$10.12	$15.62
52 Week Range	Buy	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$159.17	$36.00	$5.14	$17.67	$37.13
% Upside from Price Target	127.14% upside	57.62% upside	804.64% upside	74.66% upside	137.68% upside
Trade Information
Market Cap	$1.05 billion	$1.33 billion	$582.03 million	$1.12 billion	$891.15 million
Beta	0.95	1.73	1.96	2.51	1.91
Average Volume	222,048	451,191	1,948,630	2,451,364	1,043,517
Sales & Book Value
Annual Revenue	N/A	$73.41 million	$9.48 million	$150,000.00	$60,000.00
Price / Sales	N/A	19.60	56.74	7,377.21	14,427.67
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$27.00 per share	($3.94) per share	$0.04 per share	$0.39 per share	$3.52 per share
Price / Book	N/A	-5.80	14.21	25.94	4.44
Profitability
Net Income	$-83,950,000.00	$-236,460,000.00	$-82,760,000.00	$-172,870,000.00	$-147,720,000.00
EPS	($5.45)	($4.25)	($1.12)	($1.83)	($2.68)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-322.08%	-872.95%	-113,730.27%	N/A
Return on Equity (ROE)	-18.84%	N/A	-179.92%	-1,459.88%	-61.09%
Return on Assets (ROA)	-18.17%	-50.37%	-89.03%	-137.59%	-49.88%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	0.84%	1.01%	0.10%
Current Ratio	17.52%	3.03%	5.48%	1.77%	6.36%
Quick Ratio	17.52%	3.03%	5.44%	1.77%	6.36%
Ownership Information
Institutional Ownership Percentage	67.83%	71.64%	3.25%	53.14%	68.63%
Insider Ownership Percentage	47.69%	6.60%	3.32%	14.20%	18.20%
Miscellaneous
Employees	17	363	N/A	105	73
Shares Outstanding	15.43 million	63.00 million	946.23 million	109.40 million	55.42 million
Next Earnings Date	5/13/2020 (Estimated)	5/5/2020 (Estimated)	5/8/2020 (Estimated)	5/8/2020 (Estimated)	5/13/2020 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources